Skip to main content

Advertisement

SpringerLink
Log in

Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide in High-Risk Chronic Granulomatous Disease Patient with Invasive Mucormycosis

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data Availability

This manuscript has data included as electronic supplementary material.

References

  1. Lankester AC, Albert MH, Booth C, Gennery AR, Güngör T, Hönig T, et al. EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. Bone Marrow Transplant. 2021;56(9):2052–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol. 2010;126(3):602-10.e111.

    Article  PubMed  Google Scholar 

  3. Neven B, Diana JS, Castelle M, Magnani A, Rosain J, Touzot F, et al. Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for primary immunodeficiencies and inherited disorders in children. Biol Blood Marrow Transplant. 2019;25(7):1363–73.

    Article  PubMed  Google Scholar 

  4. Fernandes JF, Nichele S, Arcuri LJ, Ribeiro L, Zamperlini-Netto G, Loth G, et al. Outcomes after haploidentical stem cell transplantation with post-transplantation cyclophosphamide in patients with primary immunodeficiency diseases. Biol Blood Marrow Transplant. 2020;26(10):1923–9.

    Article  CAS  PubMed  Google Scholar 

  5. Parta M, Hilligoss D, Kelly C, Kwatemaa N, Theobald N, Zerbe CS, et al. Failure to prevent severe graft-versus-host disease in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in chronic granulomatous disease. J Clin Immunol. 2020;40(4):619–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Bhattad S, Raghuram CP, Porta F, Ramprakash S. Successful haploidentical transplant using post-transplant cyclophosphamide in a child with chronic granulomatous disease-first report from the Indian subcontinent. J Clin Immunol. 2021;41(4):820–4.

    Article  PubMed  Google Scholar 

  7. Hoenig M, Niehues T, Siepermann K, Jacobsen EM, Schütz C, Furlan I, et al. Successful HLA haploidentical hematopoietic SCT in chronic granulomatous disease. Bone Marrow Transplant. 2014;49(10):1337–8.

    Article  CAS  PubMed  Google Scholar 

  8. Janjindamai C, Manuyakorn W, Anurathapan U, Pakakasama S, Wattanasirichaigoon D, Kamchaisatian W, et al. Successful haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in a child with X-linked chronic granulomatous disease: a first report in Asia. Asian Pac J Allergy Immunol. 2022;40(3):278–82.

    PubMed  Google Scholar 

  9. Kapoor R, Rastogi N, Yadav SP. Haploidentical stem cell transplant with post transplant cyclophosphamide for chronic granulomatous disease with thiotepa, busulfan, and fludarabine as conditioning. J Pediatr Hematol Oncol. 2021;43(4):155–6.

    Article  PubMed  Google Scholar 

  10. Kikuta A, Ito M, Mochizuki K, Akaihata M, Nemoto K, Sano H, et al. Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction. Bone Marrow Transplant. 2006;38(10):665–9.

    Article  CAS  PubMed  Google Scholar 

  11. Morillo-Gutierrez B, Beier R, Rao K, Burroughs L, Schulz A, Ewins AM, et al. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience. Blood. 2016;128(3):440–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Regueiro-García A, Fariña-Nogueira S, Porto-Arceo JÁ, Couselo-Sánchez JM. Haploidentical stem cell transplantation in a boy with chronic granulomatous disease. Allergol Immunopathol (Madr). 2018;46(4):385–8.

    Article  PubMed  Google Scholar 

  13. Zhou L, Dong LJ, Gao ZY, Yu XJ, Lu DP. Haploidentical hematopoietic stem cell transplantation for a case with X-linked chronic granulomatous disease. Pediatr Transplant. 2017;21(1). https://doi.org/10.1111/petr.12861.

Download references

Acknowledgements

HSCT advisory team: Bénédicte Neven, Katrien Lagrou, Despina Moshous

Author information

Authors and Affiliations

  1. Department of Pediatrics, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium

    D. Ruttens

  2. Division of Pediatric Immuno-hematology and Oncology, CHC MontLégia, Liège, Belgium

    P. Philippet

  3. Inborn Errors of Immunity, Department of Immunology, Microbiology and Transplantation, KU Leuven, Herestraat 49, 3000, Leuven, Belgium

    G. Bucciol & I. Meyts

  4. Childhood Immunology, Department of Pediatrics, University Hospitals Leuven, ERN-RITA Core Member, Herestraat 49, 3000, Leuven, Belgium

    G. Bucciol & I. Meyts

Authors
  1. D. Ruttens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Philippet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Bucciol
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Meyts
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

HSCT advisory team

  • Bénédicte Neven
  • , Katrien Lagrou
  •  & Despina Moshous

Contributions

The first draft of the manuscript was written by Dries Ruttens. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to I. Meyts.

Ethics declarations

Ethics Approval

Not applicable

Consent for Publication

Not applicable

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruttens, D., Philippet, P., HSCT advisory team. et al. Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide in High-Risk Chronic Granulomatous Disease Patient with Invasive Mucormycosis. J Clin Immunol 43, 1758–1765 (2023). https://doi.org/10.1007/s10875-023-01567-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-023-01567-8

Search

Navigation